Skip to content

KEEL KEEL Share Based Compensation Restricted Stock Units

Share Based Compensation Restricted Stock Units at other companies

CBIZ logo
CBIZCBZ
$6.37M+31.1%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$15.39M-43.8%
Aeva Technologies logo
Aeva TechnologiesAEVA
$0-100%
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
1.7%+0.5pp
APA
Artisan Partners Asset Management Inc.APAM
$8.39M-1.3%
Devon Energy logo
Devon EnergyDVN
$22M-26.7%

Other financials

Income statement

See full
Revenue$37.0M-22.4%
Gross profit-$26.3M-9,631%
Operating income-$98.4M-182%
Net income-$145.4M-162%
EPS (diluted)-$0.24-118%

Balance sheet

See full
Cash & equivalents$357.3M+827%
Total debt$591.0M
Total equity$419.1M-36.6%
Total assets$1.1B

Cash flow

See full
Operating cash flow-$64.7M-243%
CapEx$10.3M-76.2%
Free cash flow-$75.0M-20.6%

Valuation

See full
Market cap$3.99B

Profitability

See full
Gross margin-7.9%-2.8pp
Operating margin-37.8%+2.0pp
Net margin-52%+24.6pp
FCF margin-259.9%+201pp

Returns & leverage

See full
Return on equity-6.1%-2.5pp
Debt / equity1.4×
Current ratio9.6×

Where this comes from

Reported directly by KEEL in its filing.

Tagged under the XBRL concept bitf:ShareBasedCompensationRestrictedStockUnits.

The official record: KEEL’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about KEEL's share based compensation restricted stock units.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KEEL's share based compensation restricted stock units?
KEEL (KEEL) reported share based compensation restricted stock units of 380K in Q4 2025.
What does share based compensation restricted stock units mean?
Reflects the non-cash compensation expense recognized for restricted stock units granted to employees, which typically vest over a service period. It serves as a primary tool for talent retention and alignment of employee interests with shareholder value. High levels of this expense indicate significant equity-based dilution and compensation costs.